Thailand Cancer Immunotherapy Market to 2032
Overview
The Thailand Cancer Immunotherapy Market is expected to reach a 1,174.07 USD Million by 2032 and is projected to grow at a CAGR of 12.69% from 2025 to 2032.
Revenue, 2024 (USD Million)
547.53
Forecast, 2032 (USD Million)
1,174.07
CAGR, 2024 - 2032
12.69%
Report Coverage
Thailand
Thailand Cancer Immunotherapy Market 2018-2032 USD Million
Thailand Cancer Immunotherapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 547.53 USD Million
- Projected Market Size (2032): 1,174.07 USD Million
- CAGR (2025-2032): 12.69%
Key Findings of Thailand Cancer Immunotherapy Market
- The Thailand Cancer Immunotherapy Market was valued at 547.53 USD Million in 2024.
- The Thailand Cancer Immunotherapy Market is likely to grow at a CAGR of 12.69% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Intravenous (IV) in Form Segment accounted for the largest share of the market with a revenue of 496.55 USD Million
- The fastest growing segment Lung Cancer in Application Segment grew Fastest with a CAGR of 16.13% during the forecast period from 2024 to 2032.
Thailand Cancer Immunotherapy Market Scope
Thailand Cancer Immunotherapy Market Segmentation & Scope
Product
- Monoclonal Antibodies
- Vaccines
- Cell Therapies
- Checkpoint Inhibitors
- Oncolytic Virus
- Immunomodulators
Application
- Lung Cancer
- Breast Cancer
- Stomach Cancer
- Colorectal Cancer
- Head & Neck Cancer
- Others
- Melanoma
- Multiple Myeloma
- Prostate Cancer
- Ovarian Cancer
- Cervical Cancer
End User
- Hospitals
- Oncology Clinics
- Homecare
- Others
Form
- Intravenous (IV)
- Intramuscular
- Oral
Distribution Channel
- Direct Tenders
- Retail Sales
- Pharmacies
Thailand Cancer Immunotherapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 547.53 USD Million |
| Market Value in 2032 | 1,174.07 USD Million |
| CAGR (2025-2032) | 12.69% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Application,End User,Form,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Thailand, leading in terms of revenue 547.53 USD Million in 2024
- Key Country: Thailand, leading in terms of revenue with value of 547.53 USD Million in 2024.
Segments and Scope
-
Thailand Cancer Immunotherapy Market to 2032, By Product
- Checkpoint Inhibitors is the largest segment in Thailand Cancer Immunotherapy Market to 2032 with a revenue of 365.00 USD Million in the year 2024.
- Checkpoint Inhibitors is the Fastest growing segment in Thailand Cancer Immunotherapy Market to 2032 with a Growth rate of 12.90 % in forecast period 2025-2032.
-
Thailand Cancer Immunotherapy Market to 2032, By Application
- Lung Cancer is the largest segment in Thailand Cancer Immunotherapy Market to 2032 with a revenue of 138.76 USD Million in the year 2024.
- Lung Cancer is the Fastest growing segment in Thailand Cancer Immunotherapy Market to 2032 with a Growth rate of 16.13 % in forecast period 2025-2032.
-
Thailand Cancer Immunotherapy Market to 2032, By End User
- Hospitals is the largest segment in Thailand Cancer Immunotherapy Market to 2032 with a revenue of 375.94 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Thailand Cancer Immunotherapy Market to 2032 with a Growth rate of 12.85 % in forecast period 2025-2032.
-
Thailand Cancer Immunotherapy Market to 2032, By Form
- Intravenous (IV) is the largest segment in Thailand Cancer Immunotherapy Market to 2032 with a revenue of 496.55 USD Million in the year 2024.
- Intravenous (IV) is the Fastest growing segment in Thailand Cancer Immunotherapy Market to 2032 with a Growth rate of 12.78 % in forecast period 2025-2032.
-
Thailand Cancer Immunotherapy Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Thailand Cancer Immunotherapy Market to 2032 with a revenue of 366.82 USD Million in the year 2024.
- Direct Tenders is the Fastest growing segment in Thailand Cancer Immunotherapy Market to 2032 with a Growth rate of 13.25 % in forecast period 2025-2032.
Thailand Cancer Immunotherapy Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Janssen Pharmaceuticals, Inc. | |||
| Bristol-Myers Squibb Company | |||
| AstraZeneca | |||
| Gilead Sciences, Inc. | |||
Thailand Cancer Immunotherapy Market Geographical Sales Distribution, 2018-2032 USD Million
Thailand Cancer Immunotherapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Thailand Cancer Immunotherapy Market is segmented based on Segmentation Product,Application,End User,Form,Distribution Channel.
Thailand Cancer Immunotherapy Market was valued at USD 547.53(Revenue in USD Million) in 2021.
Thailand Cancer Immunotherapy Market is projected to grow at a CAGR of 12.69% during the forecast period of 2024 to 2032.
The Intravenous (IV) segment is expected to dominate the Thailand Cancer Immunotherapy Market, holding a largest market share of 496.55 USD Million in 2024
Thailand Cancer Immunotherapy Market Scope
Thailand Cancer Immunotherapy Market Segmentation & Scope
Product
- Monoclonal Antibodies
- Vaccines
- Cell Therapies
- Checkpoint Inhibitors
- Oncolytic Virus
- Immunomodulators
Application
- Lung Cancer
- Breast Cancer
- Stomach Cancer
- Colorectal Cancer
- Head & Neck Cancer
- Others
- Melanoma
- Multiple Myeloma
- Prostate Cancer
- Ovarian Cancer
- Cervical Cancer
End User
- Hospitals
- Oncology Clinics
- Homecare
- Others
Form
- Intravenous (IV)
- Intramuscular
- Oral
Distribution Channel
- Direct Tenders
- Retail Sales
- Pharmacies
Frequently Asked Questions
The Thailand Cancer Immunotherapy Market is segmented based on Segmentation Product,Application,End User,Form,Distribution Channel.
Thailand Cancer Immunotherapy Market was valued at USD 547.53(Revenue in USD Million) in 2021.
Thailand Cancer Immunotherapy Market is projected to grow at a CAGR of 12.69% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Cancer Immunotherapy Market for final year is USD 1,174.07 (USD Million).
Thailand Cancer Immunotherapy Market Company Profiling
Frequently Asked Questions
The Thailand Cancer Immunotherapy Market is segmented based on Segmentation Product,Application,End User,Form,Distribution Channel.
Thailand Cancer Immunotherapy Market was valued at USD 547.53(Revenue in USD Million) in 2021.
Thailand Cancer Immunotherapy Market is projected to grow at a CAGR of 12.69% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Cancer Immunotherapy Market for final year is USD 1,174.07 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.